Panel talk about Inify’s third quarter

The third quarter of 2022 saw progress in several areas, such as the construction of the laboratory facilities in Campus Solna in Stockholm, the setup of a simulation laboratory in Linköping and the recruitment of skilled personnel, including that of Dr. Claes Lindh, the company’s new Chief Medical Officer (CMO) as of September. Some highlights of […]
Read More

INIFY Laboratories – Laboratory and recruitment on track with positive market feedback

STOCKHOLM – October 26, 2022 Inify Laboratories, a fully integrated digital ultramodern laboratory services within pathology that provides cancer diagnostics, is advancing towards opening of the company’s new laboratory, situated on Campus Solna close to Karolinska Institutet in Stockholm. “In an impressively short time, we have built a simulation lab where we further improve, test […]
Read More

Inify Laboratories AB (publ) – Extra bolagsstämma

Stockholm, Sverige, 30 augusti, 2022; Idag den 30 augusti 2022, höll Inify Laboratories AB, org. nr. 559345-4431, en extra bolagsstämma i Stockholm. Totalt var 31 807 064 aktier representerade på bolagsstämman, vilket motsvarar 70,3 % av det totala antalet aktier och röster. Stämman beslutade, med erforderlig majoritet, i samtliga ärenden i enlighet med styrelsens tidigare […]
Read More

Inify’s first ultramodern laboratory on track

STOCKHOLM – August 17 2022 – Inify Laboratories, a company providing fully digitalized pathology laboratory services for cancer diagnostics, listed in June 2022 on the Euronext Growth in Oslo, is on track in building its first ultramodern laboratory at Campus Solna, Sweden, next to world-leading healthcare. “We signed a five-year leasing contract for our office and […]
Read More

Inify’s first ultramodern laboratory on track

STOCKHOLM – August 17 2022 – Inify Laboratories, a company providing fully digitalized pathology laboratory services for cancer diagnostics, listed in June 2022 on the Euronext Growth in Oslo, is on track in building its first ultramodern laboratory at Campus Solna, Sweden, next to world-leading healthcare. “We signed a five-year leasing contract for our office […]
Read More

Notice to Extraordinary General Meeting in Inify Laboratories AB (publ)

STOCKHOLM – July 28, 2022 – Inify Laboratories AB (publ) hereby invites its shareholders to en Extraordinary General Meeting on August 30th, 2022. Please find attached the invitation including agenda and details on how to register and vote. Please contact the companys CFO Ann-Charlotte Linderoth at e-mail: for any questions regarding the EGM.
Read More

Kallelse till extra bolagsstämma i Inify Laboratories AB (publ)

STOCKHOLM – 28 juli, 2022 – Inify Laboratories AB (publ) kallar härmed sina aktieägare till en extra bolagsstämma den 30:e augusti 2022. Bifogat finns kallelse inklusive dagordning och instruktioner för registrering och röstning. Vänligen kontakta bolagets CFO Ann-Charlotte Linderoth på e-post: för frågor gällande den extra bolagsstämman.
Read More

Inify Laboratories announces the appointment of Chief Medical Officer (CMO)

Stockholm, June 29th 2022 Inify Laboratories announces the addition of specialized medical competence to the company’s management team and organization. “We warmly welcome Dr. Claes Lind to the role as CMO. His impressive background in clinical diagnostics and education fits us perfectly. He will play an instrumental role in our establishment and expansion phase. The […]
Read More
  • 1
  • 2